Drug and Medication Analysis & Statistics, September 2014 (p4)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

91-140 of about 4 200 reports

Purchase Reports From Reputable Market Research Publishers

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014, Global Markets Direct

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014', provides an overview of the Non-Alcoholic Steatohepatitis's ...

  • Industries : Drug and Medication
  • Countries : World
Partial Seizure - Pipeline Review, H2 2014, Global Markets Direct

Partial Seizure - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Partial Seizure - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Partial Seizure - Pipeline Review, H2 2014', provides an overview of the Partial Seizure's therapeutic pipeline. This report ...

  • Industries : Drug and Medication
  • Countries : World
H3N2 Infection - Pipeline Review, H2 2014, Global Markets Direct

H3N2 Infection - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

H3N2 Infection - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘H3N2 Infection - Pipeline Review, H2 2014', provides an overview of the H3N2 Infection's therapeutic pipeline. This report ...

  • Industries : Drug and Medication
  • Countries : World
Ebola Viral Infections - Pipeline Review, H2 2014, Global Markets Direct

Ebola Viral Infections - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Ebola Viral Infections - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Ebola Viral Infections - Pipeline Review, H2 2014', provides an overview of the Ebola Viral Infections's therapeutic ...

  • Industries : Drug and Medication
  • Countries : World
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, ...

  • Industries : Drug and Medication
Diabetic Nephropathy - Pipeline Review, H2 2014

Diabetic Nephropathy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Diabetic Nephropathy - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Diabetic Nephropathy - Pipeline Review, H2 2014', provides an overview of the Diabetic Nephropathy's therapeutic pipeline. ...

  • Industries : Drug and Medication
  • Countries : World
H1N1 Infection - Pipeline Review, H2 2014

H1N1 Infection - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

H1N1 Infection - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘H1N1 Infection - Pipeline Review, H2 2014', provides an overview of the H1N1 Infection's therapeutic pipeline. This report ...

  • Industries : Drug and Medication
  • Countries : World
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014', provides an overview of the Idiopathic Pulmonary ...

  • Industries : Drug and Medication
  • Countries : World
House Dust Mite Allergy - Pipeline Review, H2 2014

House Dust Mite Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

House Dust Mite Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘House Dust Mite Allergy - Pipeline Review, H2 2014', provides an overview of the House Dust Mite Allergy's therapeutic ...

  • Industries : Drug and Medication
  • Countries : World
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400

  • $ 1 995
  • Industry report
  • December 2014
  • by Plunkett Research

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 Vital industry-specific data ...

  • Industries : Drug and Medication
  • Countries : United States
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

  • Industries : Drug and Medication
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

  • $ 1 995
  • Industry report
  • December 2014
  • by Global Data

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and ...

  • Industries : Drug and Medication
  • Countries : Denmark
Novel Drug Reconstitution Systems Market, 2014 - 2024

Novel Drug Reconstitution Systems Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • December 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION In today's pharmaceutical market, many drugs are supplied in powdered formulation because of their lower shelf life in liquid formulation. The drugs are formulated into powdered form by various ...

  • Industries : Drug and Medication
Breast Cancer Drug Pathway Analyzer 2014

Breast Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 554 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 392 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Lung Cancer Drug Pathway Analyzer 2014

Lung Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 530 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pathway Analyzer 2014

Prostate Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 403 targeted molecular therapies known to affect more than 247 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Hematological Cancers Drug Pathway Analyzer 2014

Hematological Cancers Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 738 targeted molecular therapies known to affect more than 258 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Renal Cancer Drug Pathway Analyzer 2014

Renal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 235 targeted molecular therapies known to affect more than 240 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Ovarian Cancer Drug Pathway Analyzer 2014

Ovarian Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 338 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pathway Analyzer 2014

Pancreatic Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 315 targeted molecular therapies known to affect more than 252 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Brain Cancer Drug Pathway Analyzer 2014

Brain Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 235 targeted molecular therapies known to affect more than 239 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Gastrointestinal Cancer Drug Pathway Analyzer 2014

Gastrointestinal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 191 targeted molecular therapies known to affect more than 239 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 294 conjugated drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug and Medication
Brain Cancer Drug Pipeline Update 2014

Brain Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases ...

  • Industries : Drug and Medication
Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

  • Industries : Drug and Medication
Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pipeline Update 2014

Colorectal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Drug and Medication
Head and Neck Cancer Drug Pipeline Update 2014

Head and Neck Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

There are today 144 companies plus partners developing 166 drugs targeting head and neck cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug and Medication
Lung Cancer Drug Pipeline Update 2014

Lung Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication

62 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.